[go: up one dir, main page]

GB201110193D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB201110193D0
GB201110193D0 GBGB1110193.8A GB201110193A GB201110193D0 GB 201110193 D0 GB201110193 D0 GB 201110193D0 GB 201110193 A GB201110193 A GB 201110193A GB 201110193 D0 GB201110193 D0 GB 201110193D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1110193.8A
Other versions
GB2481512A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntopix Group PLC filed Critical Syntopix Group PLC
Publication of GB201110193D0 publication Critical patent/GB201110193D0/en
Publication of GB2481512A publication Critical patent/GB2481512A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
GB1110193.8A 2010-06-25 2011-06-16 Topical formulation containing usnic acid/usnate and dimethyl isosorbide Withdrawn GB2481512A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1010667.2A GB201010667D0 (en) 2010-06-25 2010-06-25 Formulations

Publications (2)

Publication Number Publication Date
GB201110193D0 true GB201110193D0 (en) 2011-08-03
GB2481512A GB2481512A (en) 2011-12-28

Family

ID=42582949

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1010667.2A Ceased GB201010667D0 (en) 2010-06-25 2010-06-25 Formulations
GB1110193.8A Withdrawn GB2481512A (en) 2010-06-25 2011-06-16 Topical formulation containing usnic acid/usnate and dimethyl isosorbide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1010667.2A Ceased GB201010667D0 (en) 2010-06-25 2010-06-25 Formulations

Country Status (1)

Country Link
GB (2) GB201010667D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021745D0 (en) * 2010-12-22 2011-02-02 Syntopix Group Plc Formulations
EP2574329A1 (en) * 2011-09-28 2013-04-03 ErlaCos GmbH Deodorant comprising dimethyl isosorbide
CA3063456A1 (en) 2017-07-19 2019-01-24 Colgate-Palmolive Company Personal care compositions comprising zinc:usnic acid complexes and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2351927A1 (en) * 1973-10-16 1975-04-24 Orissa Drebing Gmbh Deodorising cosmetic compsns. - contg. lichen acid derivs, have enhanced antimicrobial activity
JPS5246822A (en) * 1975-10-09 1977-04-14 Matsushita Electric Ind Co Ltd Method for producing electrostatic multi-needle electrode
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CA2629979A1 (en) * 2008-04-25 2009-10-25 Pharmascience Inc. Novel resveratrol compositions
GB2465633A (en) * 2008-12-01 2010-06-02 Syntopix Ltd Anti-acne formulation
GB0919210D0 (en) * 2009-11-03 2009-12-16 Syntopix Ltd Formulations

Also Published As

Publication number Publication date
GB2481512A (en) 2011-12-28
GB201010667D0 (en) 2010-08-11

Similar Documents

Publication Publication Date Title
IL223206A0 (en) Vaccine formulations
IL221409A0 (en) Abuse-resistant formulations
PL2468361T3 (en) Vildagliptin Formulations
PL2359816T3 (en) Aripiprazole formulations
ZA201300194B (en) Formulations
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
GB201110278D0 (en) Formulations
ZA201300196B (en) Formulations
GB201006326D0 (en) Formulation
GB201012589D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201007702D0 (en) Formulations
GB201007959D0 (en) Formulations
GB201008358D0 (en) Formulations
GB201008470D0 (en) Formulations
GB201018649D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201005587D0 (en) Novel formulations
GB201005992D0 (en) Formulation
GB201001978D0 (en) Formulation
GB201002000D0 (en) Formulation
GB201104049D0 (en) Formulations

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)